Theragenics returns to profitability with Q1 income of $775,000

By Angela McDaniels

Seattle, April 20 - Theragenics Corp. said net income for the first quarter ended April 2 increased to $775,000, or $0.02 per share, from a net loss of $496,000, or $0.02 per share, for the first quarter of 2005.

Consolidated revenue increased by 30% to $12.4 million for the first quarter from $9.5 million for the first quarter of 2005.

The first quarter includes the results of operations of CP Medical, acquired by Theragenics in May 2005.

"The addition of CP Medical, [the] performance of the base business and the positive effects of our 2005 restructuring has resulted in our first profitable quarter since the second quarter of 2003," chief executive officer and president M. Christine Jacobs said in a company news release.

"These results ... reinforce our resolve to continue to support growth in our brachytherapy seed and surgical products businesses while pursuing new strategic investment opportunities."

Theragenics is a medical device company based in Buford, Ga., that manufactures brachytherapy and surgical products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.